Efficacy and safety of first-ever Dengue vaccine candidate in Phase 3

被引：0
|
作者：
Riedmann, Eva M.
机构：
来源：
HUMAN VACCINES & IMMUNOTHERAPEUTICS | 2014年 / 10卷 / 08期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
引用
收藏
页码：2139 / 2139
页数：1
相关论文
共 50 条
  • [41] Immunogenicity, Safety, and Efficacy of a Tetravalent Dengue Vaccine in Children and Adolescents: An Analysis by Age Group
    Borja-Tabora, Charissa
    Fernando, Lakkumar
    Lopez Medina, Eduardo
    Reynales, Humberto
    Rivera, Luis
    Saez-Llorens, Xavier
    Sirivichayakul, Chukiat
    Yu, Delia
    Folschweiller, Nicolas
    Moss, Kelley J.
    Rauscher, Martina
    Tricou, Vianney
    Zhao, Yuan
    Biswal, Shibadas
    CLINICAL INFECTIOUS DISEASES, 2024, 80 (01) : 199 - 206
  • [42] Immunogenicity, Safety and Efficacy of the Dengue Vaccine TAK-003: A Meta-Analysis
    Flacco, Maria Elena
    Bianconi, Alessandro
    Cioni, Giovanni
    Fiore, Matteo
    Calo, Giovanna Letizia
    Imperiali, Gianmarco
    Orazi, Vittorio
    Tiseo, Marco
    Troia, Anastasia
    Rosso, Annalisa
    Manzoli, Lamberto
    VACCINES, 2024, 12 (07)
  • [43] CUMULATIVE SAFETY ASSESSMENT OF THE TAKEDA TETRAVALENT DENGUE VACCINE CANDIDATE IN PARTICIPANTS 4 TO 60 YEARS OLD
    Patel, Sanjay S.
    Rauscher, Martina
    Peng, Hang
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2021, 105 (05): : 413 - 413
  • [44] Safety and efficacy of malaria vaccine candidate R21/Matrix-M in African children: a multicentre, doubleblind, randomised, phase 3 trial
    Datoo, Mehreen S.
    Dicko, Alassane
    Tinto, Halidou
    Ouedraogo, Jean-Bosco
    Hamaluba, Mainga
    Olotu, Ally
    Beaumont, Emma
    Lopez, Fernando Ramos
    Natama, Hamtandi Magloire
    Weston, Sophie
    Chemba, Mwajuma
    Compaore, Yves Daniel
    Issiaka, Djibrilla
    Salou, Diallo
    Some, Athanase M.
    Omenda, Sharon
    Lawrie, Alison
    Bejon, Philip
    Rao, Harish
    Chandramohan, Daniel
    Roberts, Rachel
    Bharati, Sandesh
    Stockdale, Lisa
    Gairola, Sunil
    Greenwood, Brian M.
    Ewer, Katie J.
    Bradley, John
    Kulkarni, Prasad S.
    Shaligram, Umesh
    Hill, Adrian V. S.
    LANCET, 2024, 403 (10426): : 533 - 544
  • [45] Predicting 3-month mortality among patients hospitalized for first-ever acute ischemic stroke
    Chang, KC
    Tseng, MC
    Tan, TY
    Liou, CW
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2006, 105 (04) : 310 - 317
  • [46] Long-term Safety and Immunogenicity of a Tetravalent Dengue Vaccine Candidate in Children and Adults: A Randomized, Placebo-Controlled, Phase 2 Study
    Sirivichayakul, Chukiat
    Barranco-Santana, Elizabeth A.
    Rivera, Ines Esquilin
    Kilbury, Jennifer
    Raanan, Marsha
    Borkowski, Astrid
    Papadimitriou, Athanasia
    Wallace, Derek
    JOURNAL OF INFECTIOUS DISEASES, 2022, 225 (09): : 1513 - 1520
  • [47] Effects of urban community intervention on 3-year survival and recurrence after first-ever stroke
    Jiang, B
    Wang, WZ
    Wu, SP
    Du, XL
    Bao, QJ
    STROKE, 2004, 35 (06) : 1242 - 1247
  • [48] Clinical efficacy and safety of a novel tetravalent dengue vaccine in healthy children in Asia: a phase 3, randomised, observer-masked, placebo-controlled trial
    Capeding, Maria Rosario
    Ngoc Huu Tran
    Hadinegoro, Sri Rezeki S.
    Ismail, Hussain Imam H. J. Muhammad
    Chotpitayasunondh, Tawee
    Chua, Mary Noreen
    Chan Quang Luong
    Rusmil, Kusnandi
    Wirawan, Dewa Nyoman
    Nallusamy, Revathy
    Pitisuttithum, Punnee
    Thisyakorn, Usa
    Yoon, In-Kyu
    van der Vliet, Diane
    Langevin, Edith
    Laot, Thelma
    Hutagalung, Yanee
    Frago, Carina
    Boaz, Mark
    Wartel, T. Anh
    Tornieporth, Nadia G.
    Saville, Melanie
    Bouckenooghe, Alain
    LANCET, 2014, 384 (9951): : 1358 - 1365
  • [49] Resource Use and Costs of Dengue: Analysis of Data from Phase III Efficacy Studies of a Tetravalent Dengue Vaccine
    El Fezzazi, Hanna
    Branchu, Marie
    Carrasquilla, Gabriel
    Pitisuttithum, Punnee
    Perroud, Ana Paula
    Frago, Carina
    Coudeville, Laurent
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2017, 97 (06): : 1898 - 1903
  • [50] Shingles vaccine candidate strongly immunogenic in a Phase 3 trial
    不详
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2017, 13 (08) : 1734 - 1734
12345